澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of a two-component Class IIb bacteriocin in Streptococcus pyogenes by recombinase-based in vivo expression technology.

Sci Rep. 2016; 
ArmstrongBrent D,HerfstChristine A,TonialNicholas C,WakabayashiAdrienne T,ZeppaJoseph J,McCormickJo
Products/Services Used Details Operation
Gene Synthesis In addition, in an attempt to generate a counter selection system, the human herpes simplex virus-1 thymidine kinase (HSV-tk) gene was codon optimized for S. pyogenes and synthesized by Genscript. This was first cloned into pTRKL2 to fuse the MGAS8232 Gyrase A promoter (PgyrA) to the HSV-tk gene. PgyrA was amplified from MGAS8232 DNA and cloned using BamHI and NcoI while HSV-tk was amplified from pUC57::HSV-tk (Genscript) and cloned using NcoI and XbaI. Get A Quote

摘要

Streptococcus pyogenes is a globally prominent bacterial pathogen that exhibits strict tropism for the human host, yet bacterial factors responsible for the ability of S. pyogenes to compete within this limited biological niche are not well understood. Using an engineered recombinase-based in vivo expression technology (RIVET) system, we identified an in vivo-induced promoter region upstream of a predicted Class IIb bacteriocin system in the M18 serotype S. pyogenes strain MGAS8232. This promoter element was not active under in vitro laboratory conditions, but was highly induced within the mouse nasopharynx. Recombinant expression of the predicted mature S. pyogenes bacteriocin peptides (designated SpbM a... More

关键词